Cargando…
First person – Rita Serrano
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Rita Serrano is first author on ‘ Novel preclinical model for CDKL5 deficiency disorder’, p...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922022/ http://dx.doi.org/10.1242/dmm.049435 |
_version_ | 1784669439909691392 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Rita Serrano is first author on ‘ Novel preclinical model for CDKL5 deficiency disorder’, published in DMM. Rita is a postdoctoral researcher in the lab of Prof. Robert Bryson-Richardson at Monash University, Melbourne, Australia. Her research interests include neuromuscular disease modelling in zebrafish and identification of translational therapies. |
format | Online Article Text |
id | pubmed-8922022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-89220222022-03-15 First person – Rita Serrano Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Rita Serrano is first author on ‘ Novel preclinical model for CDKL5 deficiency disorder’, published in DMM. Rita is a postdoctoral researcher in the lab of Prof. Robert Bryson-Richardson at Monash University, Melbourne, Australia. Her research interests include neuromuscular disease modelling in zebrafish and identification of translational therapies. The Company of Biologists Ltd 2022-03-08 /pmc/articles/PMC8922022/ http://dx.doi.org/10.1242/dmm.049435 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Rita Serrano |
title | First person – Rita Serrano |
title_full | First person – Rita Serrano |
title_fullStr | First person – Rita Serrano |
title_full_unstemmed | First person – Rita Serrano |
title_short | First person – Rita Serrano |
title_sort | first person – rita serrano |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922022/ http://dx.doi.org/10.1242/dmm.049435 |